Accuray and University of Wisconsin-Madison Partner for Cancer Care Research
Accuray and the University of Wisconsin-Madison have formed a 10-year collaboration to enhance personalized cancer treatment through Accuray’s Stellar adaptive radiation therapy platform. This partnership focuses on advancing precision radiation therapy technologies, supporting clinical research, education, and the development of adaptive treatments to improve cancer care outcomes.
MADISON, Wis., May 15, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray’s Stellar™ adaptive…